By Steve Connor, Science Editor, Monday, 22 November 2010:
Blind patients suffering from a type of eye disease that strikes in childhood will become the second group of people in the world to receive stem cells derived from spare IVF embryos left over from fertility treatment.
The US Food and Drug Administration (FDA) has given the go-ahead for the controversial transplant of embryonic stem cells into the eyes of patients with Stargardt's macular degeneration, where the light-sensitive retina cells at the back of eye are destroyed.
Read more>>
Doctor Speedy and ME in search of medical honesty
No comments:
Post a Comment